311 related articles for article (PubMed ID: 9040512)
1. Treatment of late-state HIV infection.
Millard PS
J Fam Pract; 1997 Feb; 44(2):132-4. PubMed ID: 9040512
[No Abstract] [Full Text] [Related]
2. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
AIDS; 1998 Oct; 12(14):F151-60. PubMed ID: 9792371
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.
Henry K; Erice A; Tierney C; Balfour HH; Fischl MA; Kmack A; Liou SH; Kenton A; Hirsch MS; Phair J; Martinez A; Kahn JO
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):339-49. PubMed ID: 9833742
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group.
AIDS; 1999 Apr; 13(5):565-73. PubMed ID: 10203381
[TBL] [Abstract][Full Text] [Related]
5. FDA Committee recommends clearance for HIVID combination therapy.
AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361630
[No Abstract] [Full Text] [Related]
6. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
7. [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].
Aguirrebengoa K; Mallolas J; Uriz J; Torres Tortosa M
Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():3-9. PubMed ID: 9053024
[No Abstract] [Full Text] [Related]
8. The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus.
Molina JM; Chêne G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM
J Infect Dis; 1999 Aug; 180(2):351-8. PubMed ID: 10395849
[TBL] [Abstract][Full Text] [Related]
9. Therapy for human immunodeficiency virus infection -- what have we learned?
Corey L; Holmes KK
N Engl J Med; 1996 Oct; 335(15):1142-4. PubMed ID: 8813046
[No Abstract] [Full Text] [Related]
10. A trial comparing nucleoside monotherapy with sequential therapy with 3 drugs in HIV-infected patients.
Roca B; Olmos P; Mínguez C; Arnedo A; Usó J; Teruel C; Segarra M; Sáez-Royuela A; Simón E
Scand J Infect Dis; 1998; 30(4):426-8. PubMed ID: 9817530
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral drugs: new agents, new combinations line up against HIV.
Phillips L
Hosp Technol Ser; 1996 Jan; 15(1):1-3. PubMed ID: 10161344
[No Abstract] [Full Text] [Related]
12. Confirmation for combination AIDS therapy.
Science; 1995 Oct; 270(5233):33. PubMed ID: 7569948
[No Abstract] [Full Text] [Related]
13. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
[TBL] [Abstract][Full Text] [Related]
14. UCLA researcher demonstrates new ways to assess drug treatment in HIV-infected patients.
AIDS Patient Care STDS; 1996 Jun; 10(3):189-90. PubMed ID: 11361638
[No Abstract] [Full Text] [Related]
15. [Initial administration of a protease inhibitor delays the progression of AIDS by half time].
Dtsch Med Wochenschr; 1997 Oct; 122(42):A27. PubMed ID: 9378061
[No Abstract] [Full Text] [Related]
16. Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease.
Matthews SJ; Cersosimo RJ; Spivack ML
Pharmacotherapy; 1991; 11(6):419-48; discussion 448-9. PubMed ID: 1722897
[TBL] [Abstract][Full Text] [Related]
17. [Anti-HIV therapy (1987-1994): from nothing to confusion].
Lissen E
Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
[No Abstract] [Full Text] [Related]
18. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
[TBL] [Abstract][Full Text] [Related]
19. Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
Khajotia RR; Feigley CE; Lee E; Gu J
AIDS; 1998 Jan; 12(2):222-4. PubMed ID: 9468376
[No Abstract] [Full Text] [Related]
20. Current perspectives on antiretroviral therapy.
Fletcher CV
Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
